In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness...
In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier, which is...
Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies into a true...
An astounding 7,000 rare and orphan diseases affect more than 30 million people in the United States alone1. Rare diseases are classified as any disease that affects less...
The annual meeting of the American Society of Clinical Oncology (ASCO) was held last month and I am excited to share with you my thoughts on the highlights from this year’s...
As a scientist, I know first-hand how much time and energy go into the drug discovery and development process from day one. In fact, one of the highlights of my research...
Medication switching by pharmacies can be one of the biggest challenges faced by loss of exclusivity(LOE)brands following patient expiration and the entrance of new...
